High Tide Inc. (FRA:2LYA)
2.240
+0.010 (0.45%)
At close: Jan 9, 2026
High Tide Revenue
High Tide had revenue of 149.69M CAD in the quarter ending July 31, 2025, with 13.67% growth. This brings the company's revenue in the last twelve months to 568.25M, up 11.18% year-over-year. In the fiscal year ending October 31, 2024, High Tide had annual revenue of 522.31M with 7.10% growth.
Revenue (ttm)
568.25M CAD
Revenue Growth
+11.18%
P/S Ratio
0.56
Revenue / Employee
324.71K CAD
Employees
1,750
Market Cap
199.94M EUR
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 522.31M | 34.64M | 7.10% |
| Oct 31, 2023 | 487.67M | 130.82M | 36.66% |
| Oct 31, 2022 | 356.85M | 175.73M | 97.02% |
| Oct 31, 2021 | 181.12M | 97.86M | 117.53% |
| Oct 31, 2020 | 83.27M | 51.97M | 166.07% |
| Oct 31, 2019 | 31.29M | 22.55M | 257.69% |
| Oct 31, 2018 | 8.75M | -1.24M | -12.45% |
| Oct 31, 2017 | 9.99M | 1.55M | 18.40% |
| Oct 31, 2016 | 8.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
High Tide News
- 19 days ago - High Tide Recaps Key Milestones of 2025 - PRNewsWire
- 20 days ago - High Tide to Participate in the ICR Conference in Orlando, Florida - PRNewsWire
- 22 days ago - 3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III? - Seeking Alpha
- 24 days ago - High Tide (HITI) Explores U.S. Expansion Amid Cannabis Rescheduling Talks - GuruFocus
- 24 days ago - High Tide Welcomes Historic Executive Order on Cannabis Rescheduling and Medicare Reimbursements for CBD Products - PRNewsWire
- 4 weeks ago - Pot stocks soar on Trump push for cannabis rescheduling - BNN Bloomberg
- 4 weeks ago - Ancillary Cannabis Stocks Poised for Growth Heading Into 2026 - MarijuanaStocks
- 5 weeks ago - High Tide (HITI) Expands Canadian Presence with Three New Canna Cabana Stores - GuruFocus